Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
Brief pharmaceutical news items for April 2008.

Pharmaceutical Technology


PII Opens Development and Aseptic Facility

Pharmaceutics International (PII, Hunt Valley, MD) opened a new 30,000-ft2 , state-of-the-art development, aseptic filling, and manufacturing facility. The new Beaver Court complex complements the three existing PII facilities in Hunt Valley and those of Pharmaterials (Reading, UK).

PII's development work has moved to dedicated manufacturing space in the new building. The area consists of multiple manufacturing and containment suites to perform development projects. This area will support projects before they enter production.

The aseptic facility provides vial filling for clinical supplies and niche commercial manufacturing. The filling line will initially fill small molecules and is designed to fill containment and high-potency products. A 60-ft2 lyophilizer was installed and qualified to produce lyophilized products.

People
Bilcare NamesNew CEO

Bilcare Global Clinical Supplies (Pune, India), a provider of clinical-trial materials, appointed Vito Mangiardi, a 30-year industry veteran, as its new CEO. Mangiardi most recently served as president of North American Operations for AAI Pharma (Wilmington, NC), where he was responsible for Phase I services, formulation development, analytical development, bioanalytical, manufacturing, and stability testing, as well as Phase II–IV clinical trials.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: Pharmaceutical Technology,
Click here